ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $20,000 | -82.9% | 16,650 | -52.8% | 0.00% | -100.0% |
| Q3 2020 | $117,000 | -17.0% | 35,293 | -16.2% | 0.00% | 0.0% |
| Q2 2020 | $141,000 | -11.3% | 42,093 | +1.2% | 0.00% | 0.0% |
| Q1 2020 | $159,000 | -40.0% | 41,593 | -5.1% | 0.00% | -50.0% |
| Q4 2019 | $265,000 | -20.4% | 43,843 | -0.1% | 0.00% | 0.0% |
| Q3 2019 | $333,000 | -61.6% | 43,868 | -31.4% | 0.00% | -60.0% |
| Q2 2019 | $867,000 | +67.4% | 63,993 | -33.0% | 0.01% | +66.7% |
| Q1 2019 | $518,000 | +106.4% | 95,493 | +13.0% | 0.00% | +50.0% |
| Q4 2018 | $251,000 | -66.4% | 84,493 | -7.9% | 0.00% | -60.0% |
| Q3 2018 | $748,000 | -7.9% | 91,743 | +10.0% | 0.01% | -16.7% |
| Q2 2018 | $812,000 | +12.0% | 83,393 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $725,000 | -30.7% | 83,393 | 0.0% | 0.01% | -33.3% |
| Q4 2017 | $1,046,000 | – | 83,393 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |